United States Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Report 2016

October 2016 | 118 pages | ID: UB5740F1260EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Pipeline Drugs for Hematopoietic Stem Cell Transplantation

Revenue, means the sales value of Pipeline Drugs for Hematopoietic Stem Cell Transplantation

This report studies sales (consumption) of Pipeline Drugs for Hematopoietic Stem Cell Transplantation in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actimab-B
• Balixafortide
• BL-8040
• Burixafor
• Casin
• CDX-301
• CordSafe
• FG-6874
• HSC-835
• IBsolvMIR
• Actinium Pharmaceuticals, Inc.
• Athersys, Inc.
• BioLineRx, Ltd.
• Cell2B S.A.
• Celldex Therapeutics, Inc.
• FibroGen, Inc.
• Novartis AG
• P2D Bioscience
• Polyphor Ltd.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Pipeline Drugs for Hematopoietic Stem Cell Transplantation in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Report 2016

1 PIPELINE DRUGS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION OVERVIEW

1.1 Product Overview and Scope of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
1.2 Classification of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Pipeline Drugs for Hematopoietic Stem Cell Transplantation (2011-2021)
  1.4.1 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales and Growth Rate (2011-2021)
  1.4.2 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue and Growth Rate (2011-2021)

2 USA PIPELINE DRUGS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION COMPETITION BY MANUFACTURERS

2.1 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Average Price by Manufactures (2015 and 2016)
2.4 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Competitive Situation and Trends
  2.4.1 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Concentration Rate
  2.4.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA PIPELINE DRUGS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales and Market Share by Type (2011-2016)
3.2 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue and Market Share by Type (2011-2016)
3.3 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Price by Type (2011-2016)
3.4 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Growth Rate by Type (2011-2016)

4 USA PIPELINE DRUGS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales and Market Share by Application (2011-2016)
4.2 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA PIPELINE DRUGS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION MANUFACTURERS PROFILES/ANALYSIS

5.1 Actimab-B
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Actimab-B Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Balixafortide
  5.2.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Balixafortide Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 BL-8040
  5.3.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 BL-8040 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Burixafor
  5.4.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Burixafor Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Casin
  5.5.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Casin Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 CDX-301
  5.6.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 CDX-301 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 CordSafe
  5.7.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 CordSafe Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 FG-6874
  5.8.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 FG-6874 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 HSC-835
  5.9.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 HSC-835 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 IBsolvMIR
  5.10.2 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 IBsolvMIR Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Actinium Pharmaceuticals, Inc.
5.12 Athersys, Inc.
5.13 BioLineRx, Ltd.
5.14 Cell2B S.A.
5.15 Celldex Therapeutics, Inc.
5.16 FibroGen, Inc.
5.17 Novartis AG
5.18 P2D Bioscience
5.19 Polyphor Ltd.

6 PIPELINE DRUGS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION MANUFACTURING COST ANALYSIS

6.1 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Pipeline Drugs for Hematopoietic Stem Cell Transplantation

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Pipeline Drugs for Hematopoietic Stem Cell Transplantation Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA PIPELINE DRUGS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET FORECAST (2016-2021)

10.1 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue Forecast (2016-2021)
10.2 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Forecast by Type (2016-2021)
10.3 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Forecast by Application (2016-2021)
10.4 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
Table Classification of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
Figure USA Sales Market Share of Pipeline Drugs for Hematopoietic Stem Cell Transplantation by Type in 2015
Table Application of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
Figure USA Sales Market Share of Pipeline Drugs for Hematopoietic Stem Cell Transplantation by Application in 2015
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales and Growth Rate (2011-2021)
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue and Growth Rate (2011-2021)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales of Key Manufacturers (2015 and 2016)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Share by Manufacturers
Figure 2016 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Share by Manufacturers
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue by Manufacturers (2015 and 2016)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue Share by Manufacturers
Table 2016 USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue Share by Manufacturers
Table USA Market Pipeline Drugs for Hematopoietic Stem Cell Transplantation Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Pipeline Drugs for Hematopoietic Stem Cell Transplantation Average Price of Key Manufacturers in 2015
Figure Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Share of Top 3 Manufacturers
Figure Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Share of Top 5 Manufacturers
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales by Type (2011-2016)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Share by Type (2011-2016)
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share by Type in 2015
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue and Market Share by Type (2011-2016)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pipeline Drugs for Hematopoietic Stem Cell Transplantation by Type (2011-2016)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Price by Type (2011-2016)
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Growth Rate by Type (2011-2016)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales by Application (2011-2016)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share by Application (2011-2016)
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share by Application in 2015
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Growth Rate by Application (2011-2016)
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Growth Rate by Application (2011-2016)
Table Actimab-B Basic Information List
Table Actimab-B Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actimab-B Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Balixafortide Basic Information List
Table Balixafortide Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Balixafortide Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table BL-8040 Basic Information List
Table BL-8040 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table BL-8040 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Burixafor Basic Information List
Table Burixafor Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Burixafor Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Casin Basic Information List
Table Casin Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Casin Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table CDX-301 Basic Information List
Table CDX-301 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table CDX-301 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table CordSafe Basic Information List
Table CordSafe Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table CordSafe Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table FG-6874 Basic Information List
Table FG-6874 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table FG-6874 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table HSC-835 Basic Information List
Table HSC-835 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table HSC-835 Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table IBsolvMIR Basic Information List
Table IBsolvMIR Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table IBsolvMIR Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Actinium Pharmaceuticals, Inc. Basic Information List
Table Actinium Pharmaceuticals, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actinium Pharmaceuticals, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Athersys, Inc. Basic Information List
Table Athersys, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Athersys, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table BioLineRx, Ltd. Basic Information List
Table BioLineRx, Ltd. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioLineRx, Ltd. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Cell2B S.A. Basic Information List
Table Cell2B S.A. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell2B S.A. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Celldex Therapeutics, Inc. Basic Information List
Table Celldex Therapeutics, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table FibroGen, Inc. Basic Information List
Table FibroGen, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table FibroGen, Inc. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table P2D Bioscience Basic Information List
Table P2D Bioscience Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table P2D Bioscience Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Polyphor Ltd. Basic Information List
Table Polyphor Ltd. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales, Revenue, Price and Gross Margin (2011-2016)
Table Polyphor Ltd. Pipeline Drugs for Hematopoietic Stem Cell Transplantation Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
Figure Manufacturing Process Analysis of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
Figure Pipeline Drugs for Hematopoietic Stem Cell Transplantation Industrial Chain Analysis
Table Raw Materials Sources of Pipeline Drugs for Hematopoietic Stem Cell Transplantation Major Manufacturers in 2015
Table Major Buyers of Pipeline Drugs for Hematopoietic Stem Cell Transplantation
Table Distributors/Traders List
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Production and Growth Rate Forecast (2016-2021)
Figure USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Revenue and Growth Rate Forecast (2016-2021)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Production Forecast by Type (2016-2021)
Table USA Pipeline Drugs for Hematopoietic Stem Cell Transplantation Consumption Forecast by Application (2016-2021)